Using a Reporter Mouse to Map Known and Novel Sites of GLP-1 Receptor Expression in Peripheral Tissues of Male Mice
The DOI matches its Crossref record; 71 of the 74 references it cites were found in a registry or an index.
Abstract
Glucagon-like peptide-1 receptor (GLP-1R) activation is used in the treatment of diabetes and obesity; however, GLP-1 induces many other physiological effects with unclear mechanisms of action. To identify the cellular targets of GLP-1 and GLP-1 analogues, we generated a Glp1r.tdTomato reporter mouse expressing the reporter protein, tdTomato, in Glp1r-expressing cells. The reporter signal is expressed in all cells where GLP-1R promoter was ever active. To complement this, we histologically mapped tdTomato-fluorescence, and performed Glp-1r mRNA in situ hybridization and GLP-1R immunohistochemistry on the same tissues. In male mice, we found tdTomato signal in mucus neck, chief, and parietal cells of the stomach; Brunner’s glands; small intestinal enteroendocrine cells and intraepithelial lymphocytes; and myenteric plexus nerve fibers throughout the gastrointestinal tract. Pancreatic acinar-, β-, and δ cells, but rarely α cells, were tdTomato-positive, as were renal arteriolar smooth muscle cells; endothelial cells of the liver, portal vein, and endocardium; aortal tunica media; and lung type 1 and type 2 pneumocytes. Some thyroid follicular and parafollicular cells displayed tdTomato expression, as did tracheal cartilage chondrocytes, skin fibroblasts, and sublingual gland mucus cells. In conclusion, our reporter mouse is a powerful tool for mapping known and novel sites of GLP-1R expression in the mouse, thus enhancing our understanding of the many target cells and effects of GLP-1 and GLP-1R agonists.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Given that GLP-1Rs are expressed in the heart 21 and in blood vessels, 22”
From Management of type 2 diabetes, obesity, or nonalcoholic steatohepatitis with high‐dose GLP‐1 receptor agonists and GLP‐1 receptor‐based co‐agonists (2024) · cites this paper as [22]
Citations
Cites
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Self-citationArmstrong, M. J., Gaunt, P., Aithal, G. P., Barton, D., Hull, D., Parker, R., Hazlehurst, J. M., Guo, K., Abouda, G., Aldersley, M. A., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00803-x · Cited by 2,203
A role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950
Ban, K., Noyan-Ashraf, M. H., Hoefer, J., Bolz, S.-S., Drucker, D. J., & Husain, M. (2008) · Circulation · doi:10.1161/circulationaha.107.739938 · Cited by 1,057
Drucker, D. J., Philippe, J., Mojsov, S., Chick, W. L., & Habener, J. F. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3434 · Cited by 903
Pyke, C., Heller, R. S., Kirk, R. K., Ørskov, C., Reedtz-Runge, S., Kaastrup, P., Hvelplund, A., Bardram, L., Calatayud, D., & Knudsen, L. B. (2014) · Endocrinology · doi:10.1210/en.2013-1934 · Cited by 876
Self-citationBjerre Knudsen, L., Madsen, L. W., Andersen, S., Almholt, K., de Boer, A. S., Drucker, D. J., Gotfredsen, C., Egerod, F. L., Hegelund, A. C., Jacobsen, H., et al. (2010) · Endocrinology · doi:10.1210/en.2009-1272 · Cited by 672
Truncated GLP-1 (proglucagon 78?107-amide) inhibits gastric and pancreatic functions in man
Wettergren, A., Schjoldager, B., Mortensen, P. E., Myhre, J., Christiansen, J., & Holst, J. J. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01316798 · Cited by 670
Self-citationGlucagon-like peptide-1: a potent regulator of food intake in humans
Gutzwiller, J.-P., Göke, B., Drewe, J., Hildebrand, P., Ketterer, S., Handschin, D., Winterhalder, R., Conen, D., & Beglinger, C. (1999) · Gut · doi:10.1136/gut.44.1.81 · Cited by 576
Gupta, N. A., Mells, J., Dunham, R. M., Grakoui, A., Handy, J., Saxena, N. K., & Anania, F. A. (2010) · Hepatology · doi:10.1002/hep.23569 · Cited by 532
Research works printed but not linked: 21
- Andersen, 2011, Data from: Using a reporter mouse to map known and novel sites of GLP-1 receptor expression in male mice
- Andersen, 2011, Data from: Using a reporter mouse to map known and novel sites of GLP-1 receptor expression in male mice
- RRID:AB_2209751,
- RRID:AB_297642,
- RRID:AB_2884981,
- RRID:AB_2884980,
- RRID:AB_10854842,
- RRID:AB_2535711,
- RRID:AB_1006231,
- RRID:AB_792022,
- RRID:AB_2884977,
- RRID:AB_2884978,
- RRID:AB_2884979,
- RRID:AB_2734747,
- RRID:AB_2335678,
- RRID:AB_2884940,
- RRID:AB_2884939,
- RRID:AB_2864762,
- RRID:AB_2313606,
- Andersen, 2011, Data from: Using a reporter mouse to map known and novel sites of GLP-1 receptor expression in male mice
- Schmidtler, 1994, Rat parietal cell receptors for GLP-1-(7-36) amide: northern blot, cross-linking, and radioligand binding, Am J Physiol., 267, G423
Cited by
Nauck, M. A., Quast, D. R., Wefers, J., & Pfeiffer, A. F. H. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14496 · Cited by 388
Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease
Yabut, J. M., & Drucker, D. J. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac018 · Cited by 175
Meurot, C., Martin, C., Sudre, L., Breton, J., Bougault, C., Rattenbach, R., Bismuth, K., Jacques, C., & Berenbaum, F. (2022) · Scientific Reports · doi:10.1038/s41598-022-05323-7 · Cited by 160
Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases
Diz-Chaves, Y., Mastoor, Z., Spuch, C., González-Matías, L. C., & Mallo, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179583 · Cited by 148
“In mice, GLP-1R is present in pancreatic acinar-, β-, and δ cells, but rarely in α cells [83].”
BackgroundMethodInfluentialGLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management
Holst, J. J. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01113-9 · Cited by 125
“GLP-1R is expressed throughout the body in most organs, including the digestive and cardiovascular systems, as well as in the peripheral nervous system and the CNS 103,104 .”
Self-citationMarzook, A., Tomas, A., & Jones, B. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.678055 · Cited by 121
Actions of glucagon‐like peptide‐1 receptor ligands in the gut
Holst, J. J., Andersen, D. B., & Grunddal, K. V. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15611 · Cited by 73
Self-citationMcLean, B. A., Wong, C. K., Kaur, K. D., Seeley, R. J., & Drucker, D. J. (2021) · JCI Insight · doi:10.1172/jci.insight.153732 · Cited by 84
“Glp1r transcriptional sequences directed low level expression of a fluorescent tdTomato reporter protein within murine hepatic ECs; however, whether endogenous Glp1r mRNA transcripts are also detected in these cells was not examined (43).”
BackgroundMcLean, B. A., Wong, C. K., Kabir, M. G., & Drucker, D. J. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101641 · Cited by 82
“As Glp1r promoter-directed transgenic reporter expression was detected within a few endothelial cells localized to the mouse endocardium [38], we next assessed the localization of endogenous Glp1r mRNA transcripts within endothelial cells of the cardiac endocardium by FACS.”
BackgroundPeptides in the regulation of glucagon secretion
Andersen, D. B., & Holst, J. J. (2022) · Peptides · doi:10.1016/j.peptides.2021.170683 · Cited by 43
Self-citationSmith, C., Patterson-Cross, R., Woodward, O., Lewis, J., Chiarugi, D., Merkle, F., Gribble, F., Reimann, F., & Adriaenssens, A. (2022) · Appetite · doi:10.1016/j.appet.2022.106022 · Cited by 47
Gonzalez-Rellan, M. J., Riobello, C., Fang, S., da Silva, E. M., Koehler, J. A., Shang, R., Hammoud, R., Cao, X., Varela‐Rey, M., & Drucker, D. J. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.03.011 · Cited by 45
Shao, S., Zhang, X., Xu, Q., Pan, R., & Chen, Y. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108270 · Cited by 46
Hoffman, S., ALVARES, D. C. L., & Adeli, K. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101590 · Cited by 47
Reagents and models for detecting endogenous GLP1R and GIPR
Ast, J., Broichhagen, J., & Hodson, D. J. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103739 · Cited by 40
Grunddal, K. V., Jensen, E. P., Ørskov, C., Andersen, D. B., Windeløv, J. A., Poulsen, S. S., ROSENKILDE, M. M., Knudsen, L. B., Pyke, C., & Holst, J. J. (2021) · Endocrinology · doi:10.1210/endocr/bqab216 · Cited by 53
Self-citationGLP1R and GIPR expression and signaling in pancreatic alpha cells, beta cells and delta cells
Shilleh, A. H., Viloria, K., Broichhagen, J., Campbell, J. E., & Hodson, D. J. (2024) · Peptides · doi:10.1016/j.peptides.2024.171179 · Cited by 39
“Using this model, two independent studies showed that Glp1r expression is confined to beta cells and delta cells, and is undetectable in most alpha cells (~ 5% expression) [20,21].”
Maternal GLP-1 receptor activation inhibits fetal growth
Qiao, L., Lu, C., Zang, T., Dzyuba, B., & Shao, J. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00361.2023 · Cited by 38
Ast, J., Nasteska, D., Fine, N. H. F., Nieves, D. J., Kőszegi, Z., Lanoiselée, Y., Cuozzo, F., Viloria, K., Bacon, A., Luu, N. T., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35716-1 · Cited by 36
Stanisavljević, I., Pavlovic, S. M., Marković, B. S., Jurišević, M., Krajnović, T., Mijatović, S., Spasojević, M., Mitrović, S., Corovic, I. F., & Jovanović, I. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117668 · Cited by 35
Wang, Y., Deng, F., Zhong, X., Du, Y., Fan, X., Su, H., & Pan, T. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175730 · Cited by 32
Goldenberg, R. M., Gilbert, J. D., Manjoo, P., Pedersen, S. D., Woo, V. C., & Lovshin, J. A. (2024) · Obesity Reviews · doi:10.1111/obr.13663 · Cited by 27
Localized GLP1 receptor pre-internalization directs pancreatic alpha cell to beta cell communication
Tong, J. C. L., Frazer-Morris, C., Shilleh, A. H., Viloria, K., de Bray, A., Nair, A. M., Johnson, P., Spiers, R. M., Kobiita, A., Olaniru, O. E., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.06.009 · Cited by 25
Mendive‐Tapia, L., Miret‐Casals, L., Barth, N. D., Wang, J., de Bray, A., Beltramo, M., Robert, V., Ampè, C., Hodson, D. J., Madder, A., et al. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202302688 · Cited by 24
Holst, J. J. (2021) · Diabetes · doi:10.2337/dbi21-0026 · Cited by 23
“39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans.”
BackgroundMethodResultInfluentialSelf-citationThe Molecular Determinants of Glucagon-like Peptide Secretion by the Intestinal L cell
Brubaker, P. L. (2022) · Endocrinology · doi:10.1210/endocr/bqac159 · Cited by 23
Pro-healing impact of liraglutide on skin wounds in normoglycemic mice
Han, Y., Zhang, X., Zhao, Z., Gong, S., & Shao, S. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114050 · Cited by 22
Smits, M. M., & Holst, J. J. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3699 · Cited by 25
Self-citationFluorescent GLP1R/GIPR dual agonist probes reveal cell targets in the pancreas and brain
de Bray, A., Roberts, A. G., Armour, S. L., Tong, J., Huhn, C., Gatin‐Fraudet, B., Roßmann, K., Shilleh, A. H., Jiang, W., Burgos, N. S. F., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01342-6 · Cited by 21
Glucagon‐like peptide‐1: Are its roles as endogenous hormone and therapeutic wizard congruent?
Holst, J. J. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13433 · Cited by 25
Self-citationFrom worms to humans: Understanding intestinal lipid metabolism via model organisms
Kozan, D. W., Derrick, J. T., Ludington, W. B., & Farber, S. A. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2023.159290 · Cited by 23
Morrow, N. M., Hanson, A. A., & Mulvihill, E. E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.703966 · Cited by 19
Lansbury, E., Vana, V., Lund, M. L., Ludwig, M. Q., Mamedova, E., Gautron, L., Arnold, M., Egerod, K. L., Kuhre, R. E., Holst, J. J., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052053 · Cited by 18
Self-citationGlucose Sensing in the Hepatic Portal Vein and Its Role in Food Intake and Reward
Bacharach, S. Z., Tordoff, M. G., & Alhadeff, A. L. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.03.012 · Cited by 17
Current understanding and controversy on brain access of GLP-1 and GLP-1 receptor agonists
Feng, J., & Jin, T. (2025) · Journal of Translational Internal Medicine · doi:10.1515/jtim-2025-0026 · Cited by 16
Jensen, M. N., Israelsen, I. M. E., Wardman, J. H., Jensen, D. B., Andersen, D. B., Toft‐Bertelsen, T. L., Rath, M. F., Holst, J. J., ROSENKILDE, M. M., & MacAulay, N. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00652-x · Cited by 18
Self-citationNagasawa, Y., Katagiri, S., Nakagawa, K., Hirota, T., Yoshimi, K., Uchida, A., Hatasa, M., Komatsu, K., Shiba, T., Ohsugi, Y., et al. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105321 · Cited by 14
Goldenberg, R., Teoh, H., & Verma, S. (2023) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001084 · Cited by 11
GLP-1R agonist therapy and vaccine response: Neglected implications
van Niekerk, G., Coelmont, L., Alpizar, Y. A., Kelchtermans, L., Broeckhoven, E., & Dallmeier, K. (2024) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2024.07.006 · Cited by 11
In vitro cell cultures of Brunner’s glands from male mouse to study GLP-1 receptor function
Voetmann, L. M., Underwood, C. R., Rolin, B., Hansen, A. K., Kirk, R. K., Pyke, C., Knudsen, L. B., & Frederiksen, K. S. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00345.2021 · Cited by 10
Johnston, S. N., Tsingas, M., Ain, R., Barve, R. A., & Risbud, M. V. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1360376 · Cited by 6
GLP-1 and GIP: Magic bullet for musculoskeletal diseases?
Fang, Q., Gan, L., Liu, P., Ding, P., & Gao, Y. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.08.046 · Cited by 6
Fernandes, E. F. A., Wilbs, J., Raavé, R., Jacobsen, C. B., Toftelund, H., Helleberg, H., Boswinkel, M., Heskamp, S., Gustafsson, M., & Bjørnsdottir, I. (2022) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.2c00075 · Cited by 6
Exendin-4 imaging based on gastrointestinal GLP-1R targets for IBD diagnosis and efficacy assessment
Li, X., Liu, Y., Zhang, Z., Hai, W., Pan, Y., & Zhang, Y. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07197-z · Cited by 6
Kim, Y. C., Meng, C., Kanoo, S., Thomson, S. C., Karihaloo, A., & Vallon, V. (2026) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00109.2026 · Cited by 4
Voetmann, L. M., Rolin, B., Kirk, R. K., Knudsen, L. B., Merkestein, M., Ahnfelt‐Rønne, J., Kodal, A. L. B., Jessen, C., Ozen, A. I., Pyke, C., et al. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70510 · Cited by 3
Mendive‐Tapia, L., Miret‐Casals, L., Barth, N. D., Wang, J., de Bray, A., Beltramo, M., Robert, V., Ampè, C., Hodson, D. J., Madder, A., et al. (2023) · Angewandte Chemie · doi:10.1002/ange.202302688 · Cited by 2
Lindheimer, F., Lindner, M. J., Oos, R., Honarpisheh, M. M., Zhang, Y., Lei, Y., Buerck, L. W., Gildehaus, F. J., Lindner, S., Bartenstein, P., et al. (2023) · Frontiers in Nuclear Medicine · doi:10.3389/fnume.2023.1157480 · Cited by 2
Zawadzki, M., & Karczewska‐Kupczewska, M. (2026) · Cardiovascular Therapeutics · doi:10.1155/cdr/8388511 · Cited by 1
Semaglutide Exacerbates Stunting in Growth-Impaired Juvenile Male Mice via Reduced Energy Metabolism
Joly, A., Rebiffé, L., Dusabyinema, Y., Dellinger, J., Caillon, E., Gauthier, K. C., Leulier, F., & Vadder, F. D. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf158 · Cited by 2
Case studies in disordered satiety and appetite
(2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29218-7.15002-3
Hanson, A. A. (2022) · uO Research (University of Ottawa) · doi:10.20381/ruor-27367
Clark, M. (2023) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
De Bray, A. Y. (2025) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-gpg5vjayz
Gut Hormone Regulation of Hepatic and Intestinal Lipoprotein Production
Hoffman, S. S. (2023) · TSpace (University of Toronto) · Cited by 2
ALVARES, D. C. L. (2023) · TSpace (University of Toronto) · Cited by 1
Zhao, Z., Yue, H., Xu, W., Gong, S., & Shao, S. (2026) · Journal of Diabetes Research · doi:10.1155/jdr/6683809
Jin, C. A., Many, G. M., Spurrier, C. S. R., Borsellino, P., Wheeler, M. T., Adkins, J., Snyder, M. P., Newgard, C. B., Radom‐Aizik, S., Cooper, D. M., et al. (2026) · Physiological Genomics · doi:10.1152/physiolgenomics.00171.2026
Gut-derived glucagon-like peptides attenuate T cell-induced intestinal injury
Koehler, J. A., Baggio, L. L., Cao, X., Shang, R., Yusta, B., Chi Kin, W. O. N. G., Matthews, D., Sandoval, D. A., & Drucker, D. J. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.103115
Yue, X., Fu, H., Qian, H., Zhang, B., Xu, H., Li, D., Chen, J., Min, X., Yang, H., Wu, W., et al. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00645-8
Metadata
- Authors
- Andersen, D. B., Grunddal, K. V., Pedersen, J., Kuhre, R. E., Lund, M. L., Holst, J. J., & Ørskov, C.
- Affiliations
- University of Copenhagen (DK)
- Corresponding author
- Ørskov, Cathrine
- ORCID
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2020-12-29
- Volume
- 162
- Issue
- 3
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W3115423301
- Cited by
- 54
- References
- 74
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 6 · 2023: 10 · 2022: 14 · 2021: 8
- FWCI
- 6.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Novo Nordisk Foundation Center for Basic Metabolic Research (NNF15OC0016574)
- European Union’s Seventh Framework Programme for Research, Technological Development, and Demonstration Activities (266408)
- European Research Council (695069)
- Lundbeck Foundation (R264-2017-3492)
- Carlsberg Foundation (R264-2017-3492)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- GLP-1 receptor, tdTomato, gastrointestinal tract, enteroendocrine cells, pancreatic islets, Brunner's glands, parietal cells, myenteric plexus, thyroid follicular cells, GLP-1 receptor agonists, tissue distribution
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Animals, Fluorescent Antibody Technique, Male, Mice, Inbred C57BL, Mice, Transgenic, Tissue Distribution, Gene Expression, Genes, Reporter, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.